Overexpression of epidermal growth factor type-1 receptor (EGF-R1) in cervical cancer: implications for Cetuximab-mediated therapy in recurrent/metastatic disease.

Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ

Announcement

You can now add alternative names! Click here to add other names that you've published under.

Overexpression of epidermal growth factor type-1 receptor (EGF-R1) in cervical cancer: implications for Cetuximab-mediated therapy in recurrent/metastatic disease.

Bellone S, Frera G, Landolfi G, Romani C, Bandiera E, Tognon G, Roman JJ, Burnett AF, Pecorelli S, Santin AD. Overexpression of epidermal growth factor type-1 receptor (EGF-R1) in cervical cancer: implications for Cetuximab-mediated therapy in recurrent/metastatic disease. Gynecol Oncol. 2007 Sep; 106(3):513-20.

View in: PubMed

subject areas

Adult
Aged
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibody-Dependent Cell Cytotoxicity
Antineoplastic Agents
Cell Line, Tumor
Female
Flow Cytometry
Humans
Lymphocyte Activation
Lymphocytes
Middle Aged
Neoplasm Recurrence, Local
Uterine Cervical Neoplasms

authors with profiles

Alexander Burnett